XML 42 R30.htm IDEA: XBRL DOCUMENT v3.24.1
Income Tax Provision (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets and Liabilities Significant components of the Company’s deferred tax assets and liabilities were (in thousands):
   Year Ended 
   December 31, 
   2023   2022 
Deferred tax assets:        
Federal and state loss carryforwards  $4,847   $9,017 
Reserves, accruals and other   328    344 
Depreciation and amortization   1,329    611 
Deferred stock-based compensation   2,429    2,682 
Capitalized research and development costs   660    965 
Research and development credit carryforwards   6,744    6,655 
Total deferred tax assets   16,337    20,274 
Less: Valuation allowance   (16,337)   (20,274)
Net deferred tax assets, net  $
   $
 
Schedule of Income Taxes Provided at the Federal Statutory Rate A reconciliation of income taxes provided at the federal statutory rate (21%) to the actual income tax provision is as follows (in thousands):
   Year Ended 
   December 31, 
   2023   2022 
Income tax benefit computed at U.S. statutory rate  $277   $(6,804)
Research and development credits   
    (38)
Stock-based compensation   9    1,033 
Amortization of intangible assets   (60)   (60)
Goodwill impairment   
    2,089 
Change in fair value of warrant liabilities   (734)   
 
Valuation allowance changes affecting tax provision   506    3,774 
Other   2    6 
Income tax provision  $
   $